Tumor Embolization Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (NBCA Glue, Microspheres or Microbeads, Microcoils); Indication (Hemangioblastoma, Juvenile Nasal Angiofibroma, Meningioma, Aneurysmal Bone Cyst); End User (Hospitals, Intensive Care Units, Surgical Centers, Cancer Treatment Centers)

Report Code: TIPRE00020238 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Tumor embolization is a minimally invasive procedure done prior to the planned surgical removal of a tumor. However, sometimes, surgical resection becomes challenging and risky due to excessive blood loss as few tumors like the brain, neck, and spine have a large blood supply. Tumor embolization can be used for malignant and benign tumors as well.

MARKET DYNAMICS

The tumor embolization market has seen strong revenue generation growth in the last few years because of growing prevalence of cancer, increasing preference for minimally invasive treatment procedures, rising hospitals establishments, and technological progress in the field of oncology.. However, due to lack of advanced hospital and surgical center establishments may impacts the tumor embolization market negatively.

MARKET SCOPE

The "Tumor embolization Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of tumor embolization market with detailed market segmentation by product type, indication, and end user. The tumor embolization market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in tumor embolization market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The tumor embolization market is segmented on the basis of product type, indication, and end user. Based on product type, the market is segmented as NBCA glue, microspheres or microbeads, and microcoils. By indication, market is segmented as hemangioblastoma, juvenile nasal angiofibroma, meningioma, and aneurysmal bone cyst. By end user, the market is segmented as hospitals, intensive care units, surgical centers, cancer treatment centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the tumor embolization market based onvarious segments.It also provides market size and forecast estimates from year 2020 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The tumor embolization market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting tumor embolization market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the tumor embolization market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the tumor embolization market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from tumor embolization market are anticipated to have lucrative growth opportunities in the future with the rising demand for tumor embolization in the global market. Below mentioned is the list of few companies engaged in the tumor embolization market.

The report also includes the profiles of key players in tumor embolization market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and product type, indication, and end users offered, financial information of last 3 years, key development in past five years.

  •  MICROVENTION INC.
  •  KANEKA PHARMA EUROPE NV GERMAN BRANCH
  •  PENUMBRA, INC
  •  DEPUY SYNTHES
  •  COOK
  •  DEUTSCHLAND GMBH AND CO. KG
  •  BOSTON SCIENTIFIC CORPORATION
  •  BALT EXTRUSION
  •  ANGIODYNAMICS
  •  VARIAN MEDICAL SYSTEMS, INC.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tumor Embolization Market - By Product Type
1.3.2 Tumor Embolization Market - By Indication
1.3.3 Tumor Embolization Market - By End User
1.3.4 Tumor Embolization Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TUMOR EMBOLIZATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TUMOR EMBOLIZATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TUMOR EMBOLIZATION MARKET - GLOBAL MARKET ANALYSIS
6.1. TUMOR EMBOLIZATION - GLOBAL MARKET OVERVIEW
6.2. TUMOR EMBOLIZATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. TUMOR EMBOLIZATION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. NBCA GLUE
7.3.1. Overview
7.3.2. NBCA Glue Market Forecast and Analysis
7.4. MICROSPHERES OR MICROBEADS
7.4.1. Overview
7.4.2. Microspheres or Microbeads Market Forecast and Analysis
7.5. MICROCOILS
7.5.1. Overview
7.5.2. Microcoils Market Forecast and Analysis
8. TUMOR EMBOLIZATION MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. HEMANGIOBLASTOMA
8.3.1. Overview
8.3.2. Hemangioblastoma Market Forecast and Analysis
8.4. JUVENILE NASAL ANGIOFIBROMA
8.4.1. Overview
8.4.2. Juvenile Nasal Angiofibroma Market Forecast and Analysis
8.5. MENINGIOMA
8.5.1. Overview
8.5.2. Meningioma Market Forecast and Analysis
8.6. ANEURYSMAL BONE CYST
8.6.1. Overview
8.6.2. Aneurysmal Bone Cyst Market Forecast and Analysis
9. TUMOR EMBOLIZATION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. INTENSIVE CARE UNITS
9.4.1. Overview
9.4.2. Intensive Care Units Market Forecast and Analysis
9.5. SURGICAL CENTERS
9.5.1. Overview
9.5.2. Surgical Centers Market Forecast and Analysis
9.6. CANCER TREATMENT CENTERS
9.6.1. Overview
9.6.2. Cancer Treatment Centers Market Forecast and Analysis
10. TUMOR EMBOLIZATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Tumor Embolization Market Overview
10.1.2 North America Tumor Embolization Market Forecasts and Analysis
10.1.3 North America Tumor Embolization Market Forecasts and Analysis - By Product Type
10.1.4 North America Tumor Embolization Market Forecasts and Analysis - By Indication
10.1.5 North America Tumor Embolization Market Forecasts and Analysis - By End User
10.1.6 North America Tumor Embolization Market Forecasts and Analysis - By Countries
10.1.6.1 United States Tumor Embolization Market
10.1.6.1.1 United States Tumor Embolization Market by Product Type
10.1.6.1.2 United States Tumor Embolization Market by Indication
10.1.6.1.3 United States Tumor Embolization Market by End User
10.1.6.2 Canada Tumor Embolization Market
10.1.6.2.1 Canada Tumor Embolization Market by Product Type
10.1.6.2.2 Canada Tumor Embolization Market by Indication
10.1.6.2.3 Canada Tumor Embolization Market by End User
10.1.6.3 Mexico Tumor Embolization Market
10.1.6.3.1 Mexico Tumor Embolization Market by Product Type
10.1.6.3.2 Mexico Tumor Embolization Market by Indication
10.1.6.3.3 Mexico Tumor Embolization Market by End User
10.2. EUROPE
10.2.1 Europe Tumor Embolization Market Overview
10.2.2 Europe Tumor Embolization Market Forecasts and Analysis
10.2.3 Europe Tumor Embolization Market Forecasts and Analysis - By Product Type
10.2.4 Europe Tumor Embolization Market Forecasts and Analysis - By Indication
10.2.5 Europe Tumor Embolization Market Forecasts and Analysis - By End User
10.2.6 Europe Tumor Embolization Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Tumor Embolization Market
10.2.6.1.1 Germany Tumor Embolization Market by Product Type
10.2.6.1.2 Germany Tumor Embolization Market by Indication
10.2.6.1.3 Germany Tumor Embolization Market by End User
10.2.6.2 France Tumor Embolization Market
10.2.6.2.1 France Tumor Embolization Market by Product Type
10.2.6.2.2 France Tumor Embolization Market by Indication
10.2.6.2.3 France Tumor Embolization Market by End User
10.2.6.3 Italy Tumor Embolization Market
10.2.6.3.1 Italy Tumor Embolization Market by Product Type
10.2.6.3.2 Italy Tumor Embolization Market by Indication
10.2.6.3.3 Italy Tumor Embolization Market by End User
10.2.6.4 Spain Tumor Embolization Market
10.2.6.4.1 Spain Tumor Embolization Market by Product Type
10.2.6.4.2 Spain Tumor Embolization Market by Indication
10.2.6.4.3 Spain Tumor Embolization Market by End User
10.2.6.5 United Kingdom Tumor Embolization Market
10.2.6.5.1 United Kingdom Tumor Embolization Market by Product Type
10.2.6.5.2 United Kingdom Tumor Embolization Market by Indication
10.2.6.5.3 United Kingdom Tumor Embolization Market by End User
10.2.6.6 Rest of Europe Tumor Embolization Market
10.2.6.6.1 Rest of Europe Tumor Embolization Market by Product Type
10.2.6.6.2 Rest of Europe Tumor Embolization Market by Indication
10.2.6.6.3 Rest of Europe Tumor Embolization Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Tumor Embolization Market Overview
10.3.2 Asia-Pacific Tumor Embolization Market Forecasts and Analysis
10.3.3 Asia-Pacific Tumor Embolization Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Tumor Embolization Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Tumor Embolization Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Tumor Embolization Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Tumor Embolization Market
10.3.6.1.1 Australia Tumor Embolization Market by Product Type
10.3.6.1.2 Australia Tumor Embolization Market by Indication
10.3.6.1.3 Australia Tumor Embolization Market by End User
10.3.6.2 China Tumor Embolization Market
10.3.6.2.1 China Tumor Embolization Market by Product Type
10.3.6.2.2 China Tumor Embolization Market by Indication
10.3.6.2.3 China Tumor Embolization Market by End User
10.3.6.3 India Tumor Embolization Market
10.3.6.3.1 India Tumor Embolization Market by Product Type
10.3.6.3.2 India Tumor Embolization Market by Indication
10.3.6.3.3 India Tumor Embolization Market by End User
10.3.6.4 Japan Tumor Embolization Market
10.3.6.4.1 Japan Tumor Embolization Market by Product Type
10.3.6.4.2 Japan Tumor Embolization Market by Indication
10.3.6.4.3 Japan Tumor Embolization Market by End User
10.3.6.5 South Korea Tumor Embolization Market
10.3.6.5.1 South Korea Tumor Embolization Market by Product Type
10.3.6.5.2 South Korea Tumor Embolization Market by Indication
10.3.6.5.3 South Korea Tumor Embolization Market by End User
10.3.6.6 Rest of Asia-Pacific Tumor Embolization Market
10.3.6.6.1 Rest of Asia-Pacific Tumor Embolization Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Tumor Embolization Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Tumor Embolization Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Tumor Embolization Market Overview
10.4.2 Middle East and Africa Tumor Embolization Market Forecasts and Analysis
10.4.3 Middle East and Africa Tumor Embolization Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Tumor Embolization Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Tumor Embolization Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Tumor Embolization Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Tumor Embolization Market
10.4.6.1.1 South Africa Tumor Embolization Market by Product Type
10.4.6.1.2 South Africa Tumor Embolization Market by Indication
10.4.6.1.3 South Africa Tumor Embolization Market by End User
10.4.6.2 Saudi Arabia Tumor Embolization Market
10.4.6.2.1 Saudi Arabia Tumor Embolization Market by Product Type
10.4.6.2.2 Saudi Arabia Tumor Embolization Market by Indication
10.4.6.2.3 Saudi Arabia Tumor Embolization Market by End User
10.4.6.3 U.A.E Tumor Embolization Market
10.4.6.3.1 U.A.E Tumor Embolization Market by Product Type
10.4.6.3.2 U.A.E Tumor Embolization Market by Indication
10.4.6.3.3 U.A.E Tumor Embolization Market by End User
10.4.6.4 Rest of Middle East and Africa Tumor Embolization Market
10.4.6.4.1 Rest of Middle East and Africa Tumor Embolization Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Tumor Embolization Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Tumor Embolization Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Tumor Embolization Market Overview
10.5.2 South and Central America Tumor Embolization Market Forecasts and Analysis
10.5.3 South and Central America Tumor Embolization Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Tumor Embolization Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Tumor Embolization Market Forecasts and Analysis - By End User
10.5.6 South and Central America Tumor Embolization Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Tumor Embolization Market
10.5.6.1.1 Brazil Tumor Embolization Market by Product Type
10.5.6.1.2 Brazil Tumor Embolization Market by Indication
10.5.6.1.3 Brazil Tumor Embolization Market by End User
10.5.6.2 Argentina Tumor Embolization Market
10.5.6.2.1 Argentina Tumor Embolization Market by Product Type
10.5.6.2.2 Argentina Tumor Embolization Market by Indication
10.5.6.2.3 Argentina Tumor Embolization Market by End User
10.5.6.3 Rest of South and Central America Tumor Embolization Market
10.5.6.3.1 Rest of South and Central America Tumor Embolization Market by Product Type
10.5.6.3.2 Rest of South and Central America Tumor Embolization Market by Indication
10.5.6.3.3 Rest of South and Central America Tumor Embolization Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUMOR EMBOLIZATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. TUMOR EMBOLIZATION MARKET, KEY COMPANY PROFILES
13.1. MICROVENTION INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. KANEKA PHARMA EUROPE NV GERMAN BRANCH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PENUMBRA, INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DEPUY SYNTHES
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. COOK
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. DEUTSCHLAND GMBH AND CO. KG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BOSTON SCIENTIFIC CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BALT EXTRUSION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ANGIODYNAMICS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VARIAN MEDICAL SYSTEMS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. MICROVENTION INC.
2. KANEKA PHARMA EUROPE NV GERMAN BRANCH
3. PENUMBRA, INC
4. DEPUY SYNTHES
5. COOK
6. DEUTSCHLAND GMBH AND CO. KG
7. BOSTON SCIENTIFIC CORPORATION
8. BALT EXTRUSION
9. ANGIODYNAMICS
10. VARIAN MEDICAL SYSTEMS, INC.

TIPRE00020238
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking